FEATURED COMPANIES
- Abbott Biologicals B.V.
- BioDiem
- Daiichi-Sankyo
- Gamma Vaccines Pty Ltd.
- Innovio Pharmaceuticals
- Mylan N.V.
Introduction
Flu is a contagious respiratory illness caused by the influenza virus that affects the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times lead to death. Fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, fatigue are the common symptoms of the disease.
There are four types of influenza viruses: A, B, C and D. Human influenza A and B viruses can cause seasonal epidemics (known as the flu season) almost every winter in the United States. Influenza A virus is the only influenza virus known to cause flu pandemics, i.e., global epidemics of flu disease. A pandemic can occur when a new and a different influenza A virus emerges affecting people with the ability to spread efficiently. Influenza type C infections generally causes mild illness and usually do not cause human flu epidemics. Influenza D viruses primarily affects the cattle and are not known to cause illnesses amongst people.
The best way to prevent flu is by getting a flu vaccine each year. The influenza vaccine is recommended by the World Health Organization (WHO) for high-risk groups, such as pregnant women, children, the elderly, health-care workers, and people who have chronic illnesses. The United States Centers for Disease Control and Prevention (CDC) recommends the influenza vaccine for those aged six months or older who do not have contraindications. In healthy children over the age of two years, the vaccine reduces the chance of getting an influenza by around two-thirds. In those, with chronic obstructive pulmonary diseases, vaccinations can help to reduce exacerbations.
Market Dynamics
Drivers
Restraints
Opportunities
Segments Covered
The Global Influenza Vaccine Market is segmented on the basis of Age Group, Vaccine Type, Valency and Distribution Channel.
Global Influenza Vaccine Market, By Age Group
Global Influenza Vaccine Market, By Vaccine Type
Global Influenza Vaccine Market, By Valency
Global Influenza Vaccine Market, By Distribution Channel
Company Profiles
The companies covered in this report are:
IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.
Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.
Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance.
Why buy this report?
The report offers a comprehensive evaluation of the global Influenza vaccine market. The report includes an in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter’s 5 force model and Ansoff Matrix. Impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using IGR Competitive Quadrant, a Proprietary competitive positioning tool.
Report Highlights:
Flu is a contagious respiratory illness caused by the influenza virus that affects the nose, throat, and sometimes the lungs. It can cause mild to severe illness, and at times lead to death. Fever, cough, sore throat, runny or stuffy nose, muscle or body aches, headaches, fatigue are the common symptoms of the disease.
There are four types of influenza viruses: A, B, C and D. Human influenza A and B viruses can cause seasonal epidemics (known as the flu season) almost every winter in the United States. Influenza A virus is the only influenza virus known to cause flu pandemics, i.e., global epidemics of flu disease. A pandemic can occur when a new and a different influenza A virus emerges affecting people with the ability to spread efficiently. Influenza type C infections generally causes mild illness and usually do not cause human flu epidemics. Influenza D viruses primarily affects the cattle and are not known to cause illnesses amongst people.
The best way to prevent flu is by getting a flu vaccine each year. The influenza vaccine is recommended by the World Health Organization (WHO) for high-risk groups, such as pregnant women, children, the elderly, health-care workers, and people who have chronic illnesses. The United States Centers for Disease Control and Prevention (CDC) recommends the influenza vaccine for those aged six months or older who do not have contraindications. In healthy children over the age of two years, the vaccine reduces the chance of getting an influenza by around two-thirds. In those, with chronic obstructive pulmonary diseases, vaccinations can help to reduce exacerbations.
Market Dynamics
Drivers
- Increasing prevalence of influenza
- Increasing research based activities in Vaccines
- Technological progress in vaccine administration
Restraints
- Stringent Regulations
- High costs associated with the Vaccine Development
Opportunities
- High growth prospects in emerging economies
Segments Covered
The Global Influenza Vaccine Market is segmented on the basis of Age Group, Vaccine Type, Valency and Distribution Channel.
Global Influenza Vaccine Market, By Age Group
- Paediatric Vaccination
- Adult Vaccination
Global Influenza Vaccine Market, By Vaccine Type
- Inactivated
- Live Attenuated
- Recombinant
Global Influenza Vaccine Market, By Valency
- Trivalent
- Quadrivalent
Global Influenza Vaccine Market, By Distribution Channel
- Hospital & Clinic
- Government Suppliers
- Retail Pharmacy
Company Profiles
The companies covered in this report are:
- Abbott Biologicals B.V.
- AstraZeneca
- BioDiem
- CSL
- Daiichi-Sankyo
- Emergent BioSolutions
- Fluart Innovative Vaccines Kft.
- Gamma Vaccines Pty Ltd.
- GlaxoSmithKline plc
- Innovio Pharmaceuticals
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer Inc.
- Sanofi S.A.
- Seqirus GmbH
IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.
Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.
Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance.
Why buy this report?
The report offers a comprehensive evaluation of the global Influenza vaccine market. The report includes an in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter’s 5 force model and Ansoff Matrix. Impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using IGR Competitive Quadrant, a Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown
FEATURED COMPANIES
- Abbott Biologicals B.V.
- BioDiem
- Daiichi-Sankyo
- Gamma Vaccines Pty Ltd.
- Innovio Pharmaceuticals
- Mylan N.V.
1 Report Description
2 Research Methodology
4 Market Overview
5 Market Analysis
6 Global Influenza Vaccine Market, By Age Group
7 Global Influenza Vaccine Market, By Vaccine Type
8 Global Influenza Vaccine Market, By Valency
9 Global Influenza Vaccine Market, By Distribution Channel
10 Global Influenza Vaccine Market, By Geography
11 Competitive Landscape
12 Company Profiles
13 Appendix
Note: Product cover images may vary from those shown
- Abbott Biologicals B.V.
- AstraZeneca
- BioDiem
- CSL
- Daiichi-Sankyo
- Emergent BioSolutions
- Fluart Innovative Vaccines Kft.
- Gamma Vaccines Pty Ltd.
- GlaxoSmithKline plc
- Innovio Pharmaceuticals
- Merck & Co., Inc.
- Mylan N.V.
- Pfizer Inc.
- Sanofi S.A.
- Seqirus GmbH
Note: Product cover images may vary from those shown